发明名称 Combination of Brexpiprazole and Nalmefene and Use Thereof for Treating Substance-Related Disorders
摘要 A medicament comprising (I) brexpiprazole or a pharmaceutically acceptable salt thereof, and (II) nalmefene or a pharmaceutically acceptable salt thereof in combination, wherein brexpiprazole or a pharmaceutically acceptable salt thereof, and nalmefene or a pharmaceutically acceptable salt thereof are contained in a single preparation, or a pharmaceutical composition containing brexpiprazole or a pharmaceutically acceptable salt thereof and a pharmaceutical composition containing nalmefene or a pharmaceutically acceptable salt thereof are formulated for use in combination. The medicament is used for the prophylaxis or treatment of a substance-related disorder, preferably an alcohol-related disorder.
申请公布号 US2017042887(A1) 申请公布日期 2017.02.16
申请号 US201515305782 申请日期 2015.04.22
申请人 OTSUKA PHARMACEUTICAL. CO., LTD. ;H. LUNDBECK A/S 发明人 MAEDA Kenji;NAKAMURA Mai
分类号 A61K31/496;A61K31/485 主分类号 A61K31/496
代理机构 代理人
主权项 1. A medicament comprising (I) brexpiprazole or a pharmaceutically acceptable salt thereof, and (II) nalmefene or a pharmaceutically acceptable salt thereof in combination, wherein brexpiprazole or a pharmaceutically acceptable salt thereof, and nalmefene or a pharmaceutically acceptable salt thereof are contained in a single preparation, or a pharmaceutical composition containing brexpiprazole or a pharmaceutically acceptable salt thereof and a pharmaceutical composition containing nalmefene or a pharmaceutically acceptable salt thereof are formulated for use in combination.
地址 Tokyo JP